AstraZeneca PLC's Fiscal Year is From January To December.
The item "Ebitda-Interest-Coverage" stands at 9.30 as of 09/30/2025.
As of the end of AstraZeneca PLC's third quarter, the item "Ebitda Interest Coverage" stands at 9.30. This represents an increase of 14.97 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.44 percent compared to the value the year prior.
The 1 year change in percent is 6.44.
The 3 year change in percent is 43.01.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebitda Interest Coverage | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebitda Interest Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebitda Interest Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebitda Interest Coverage | 317,433,206,677.55 |
![]() | Novartis AG - Ebitda Interest Coverage | 255,096,620,580.91 |